NCT05502510

Brief Summary

One in ten births will occur prior to 37 weeks of gestation leading to serious complications such as problems with lung, heart and brain function and an increased risk of infant mortality. Solutions exist to treat risk factors related to preterm birth but these solutions require timely identification of the risks which is often not possible within regular prenatal care. This study will evaluate MyHealthyPregnancy, an application that monitors for common risks associated with preterm birth and recommends solutions to the expectant mother and care team.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,344

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 23, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

2.4 years

First QC Date

August 12, 2022

Last Update Submit

August 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gestational Age at Birth

    Gestational age at birth will be measured using each patients electronic health record. The average treatment effect will be calculated using linear regression comparing MHP and usual care cohorts. Efficacy of the application will be assessed using a dose-response model to evaluate how use of the application affects gestational age at birth.

    Baseline to 40 Weeks

Secondary Outcomes (9)

  • Prenatal Births

    Baseline to 37 Weeks

  • Depression Rates

    Baseline to 40 Weeks

  • Anxiety Rates

    Baseline to 40 Weeks

  • Referrals to Behavioral Health Specialists

    Baseline to 40 Weeks

  • Referrals to Social Workers

    Baseline to 40 Weeks

  • +4 more secondary outcomes

Study Arms (2)

MyHealthyPregnancy (MHP)

Use of the MyHealthyPregnancy application in conjunction with usual care.

Behavioral: MyHealthyPregnancy

Usual Prenatal Care (usual care)

Usual prenatal care consisting of biweekly visits with the patient care team.

Interventions

MyHealthyPregnancy is a mobile application prescribed to expectant mothers in conjunction with normal prenatal care. The application uses behavioral decision science principles to identify risks of preterm birth and alert the mother and care team of these risks.

MyHealthyPregnancy (MHP)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant people offered a prescription for MyHealthyPregnancy who were at least 18 years of age, pregnant, received care at UPMC, and delivered at a UPMC hospital

You may qualify if:

  • Offered a prescription for MyHealthyPregnancy
  • + years of age
  • Pregnant
  • Seeking care at a UPMC hospital
  • Delivered at a UPMC hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2022

First Posted

August 16, 2022

Study Start

September 23, 2019

Primary Completion

February 28, 2022

Study Completion

February 28, 2022

Last Updated

August 16, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Analytic Code Access

Locations